iCAD is at the forefront of developing advanced AI-powered solutions aimed at enhancing breast cancer detection and risk assessment. Their flagship product, the ProFound Breast Health Suite, integrates three key components: Detection, Density, and Risk. ProFound Detection utilizes cutting-edge artificial intelligence to significantly improve the accuracy and efficiency of cancer detection during mammogram screenings, boasting up to twice the clinical performance compared to other AI platforms. This technology is designed to identify cancers at earlier stages, thereby increasing the chances of successful treatment and improving patient outcomes. Additionally, the Density Assessment tool provides objective and reliable scoring of breast density, which is crucial since dense breast tissue can elevate cancer risk significantly.

Furthermore, iCAD's ProFound Risk model represents a breakthrough in personalized cancer screening, being the first image-based risk assessment tool that is 2.4 times more accurate than traditional models. This innovative approach allows for the identification of women at high risk of developing breast cancer, enabling proactive measures to be taken before their next screening. iCAD's commitment to leveraging clinical evidence and proven patient outcomes underpins their mission to create a world where cancer cannot hide, ultimately aiming to save more lives through early detection and tailored treatment strategies.

United States

At iCAD, we believe that is possible to create a world where cancer can't hide.  Leveraging the power of artificial intellegence (AI), we empower healthcare providers to more accurately, reliably, and quickly detect disease and improve outcomes.
 
The ProFound Breast Health Suite offers a comprehensive portfolio of clinically proven AI technologies for breast cancer detection, automated breast density assessment, and short-term personalized risk evaluation providing certainty and peace of mind - Optimizing every patient's opportunity to live better, longer lives!

To learn more, visit www.icadmed.com.

iCAD

Company Details